Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-05-26Clinical Trial Update: Combination of Capecitabine and Oxaliplatin in Patients With Relapsed or Refractory Gastric Cancer [Phase 2]
A Phase 2 trial evaluating the combination of capecitabine and oxaliplatin in patients with relapsed or refractory gastric cancer has been s…
-
CLINICAL_TRIALS trial_result · 2010-05-26Clinical Trial Update: S-1 and Irinotecan Combination Chemotherapy for Advanced Gastric Cancer [Phase 2]
Phase 2 clinical trial evaluating S-1 and irinotecan combination chemotherapy for advanced gastric cancer; status is unknown.
-
CLINICAL_TRIALS trial_result · 2010-05-14Clinical Trial Update: Efficacy of Cetuximab in Combination With Irinotecan and 5- FU/FA in Treatment of Metastatic Gastric Cancer [Phase 2]
Phase 2 study evaluating cetuximab with irinotecan and 5-FU/folinic acid in metastatic gastric cancer. The trial has completed and reported …
-
CLINICAL_TRIALS research · 2010-03-22Clinical Trial Update: Study of S-1 and Oxaliplatin as Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer [Phase 2]
This entry summarizes a Phase 2 study evaluating S-1 in combination with oxaliplatin as neoadjuvant chemotherapy for locally advanced gastri…
-
FDA approval · 2010-03-05FDA Approved: FLUOROURACIL — Original Application (Taro Pharmaceuticals U.S.A., Inc.)
The FDA approved the original application for a generic fluorouracil product manufactured by Taro Pharmaceuticals U.S.A., Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-03-02Clinical Trial Update: A Study of Vinflunine in Patients With Gastric Cancer [Phase 2, Phase 3]
A Phase 2/3 study of vinflunine in gastric cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2010-01-27Clinical Trial Update: Study of Weekly DCF to Treat Advanced Gastric Cancer [Phase 2]
Phase 2 trial evaluating weekly DCF (docetaxel, cisplatin, and 5-fluorouracil) for advanced gastric cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2010-01-15Clinical Trial Update: Phase II Study of Epirubicin, Cisplatin and Capecitabine (ECX) Versus Cisplatin and Capecitabine (CX) for Advanced Gastric Cancer (AGC) [Phase 2]
This Phase II trial compared the ECX regimen (epirubicin, cisplatin, capecitabine) with cisplatin plus capecitabine (CX) for advanced gastri…
-
CLINICAL_TRIALS trial_result · 2009-12-23Clinical Trial Update: Study of Cetuximab to Treat Gastric Cancer [Phase 2]
A Phase 2 clinical trial evaluating cetuximab for gastric cancer conducted by Fudan University has completed.
-
CLINICAL_TRIALS trial_result · 2009-12-16Clinical Trial Update: Phase II Trial Evaluating Irinotecan and Capecitabine Relapsed/Refractory Upper GI Tumours [Phase 4]
The Phase II trial of irinotecan plus capecitabine for relapsed/refractory upper gastrointestinal tumours has completed.
-
CLINICAL_TRIALS trial_result · 2009-11-26Clinical Trial Update: An International Phase 2 Study Of SU011248 In Patients With Advanced / Metastatic Gastric Cancer Failing Chemotherapy [Phase 2]
Pfizer-sponsored Phase 2 study of SU011248 in patients with advanced or metastatic gastric cancer that progressed after chemotherapy; result…
-
CLINICAL_TRIALS trial_result · 2009-11-19Clinical Trial Update: Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer [Phase 1, Phase 2]
This document reports the completion of Phase 1/Phase 2 clinical trials evaluating an HLA-A*2402-restricted peptide vaccine for gastric canc…
-
CLINICAL_TRIALS trial_result · 2009-11-19Clinical Trial Update: Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer [Phase 1, Phase 2]
This clinical trial update reports the completion of a Phase 1/Phase 2 study of an HLA-A*0201-restricted peptide vaccine for gastric cancer.
-
CLINICAL_TRIALS trial_result · 2009-10-27Clinical Trial Update: Efficacy Study of Helicobacter Pylori Eradication in Patients Undergoing Subtotal Gastrectomy for Gastric Cancer [Phase 2]
Phase 2 efficacy trial evaluating Helicobacter pylori eradication in patients undergoing subtotal gastrectomy for gastric cancer has complet…
-
CLINICAL_TRIALS trial_result · 2009-09-28Clinical Trial Update: Combination of CPT-11 and LoHP vs Combination of 5-FU, Leucovorin and LoHP as 1st Line Treatment in Gastric Patients [Phase 2]
Phase 2 clinical trial comparing irinotecan-based therapy with LoHP versus a 5-FU/leucovorin/LoHP regimen as first-line treatment in gastric…
-
CLINICAL_TRIALS trial_result · 2009-09-28Clinical Trial Update: Study of Pemetrexed Plus Cisplatin in Advanced Gastric Cancer [Phase 1, Phase 2]
This clinical trial update reports the completion and posting of results for a Phase 1/Phase 2 study of pemetrexed plus cisplatin in advance…
-
CLINICAL_TRIALS trial_result · 2009-09-21Clinical Trial Update: A Phase I/II Study of S-1 and Weekly Docetaxel for Metastatic Gastric Carcinoma [Phase 1, Phase 2]
Completed Phase I/II clinical trial evaluating S-1 in combination with weekly docetaxel for metastatic gastric cancer.
-
CLINICAL_TRIALS research · 2009-09-21Clinical Trial Update: Docetaxel Versus Docetaxel Plus Cisplatin Versus Docetaxel Plus S-1 as Second-line Chemotherapy in Metastatic Gastric Cancer [Phase 2]
Phase 2 clinical trial comparing docetaxel alone versus docetaxel plus cisplatin versus docetaxel plus S-1 as second-line chemotherapy for m…
-
CLINICAL_TRIALS trial_result · 2009-09-18Clinical Trial Update: A Phase II Study of Irinotecan, Oxaliplatin, Plus TS-1 in Untreated Metastatic Gastric Cancer [Phase 2]
Phase II trial evaluating a triplet chemotherapy regimen of irinotecan, oxaliplatin, and TS-1 in untreated metastatic gastric cancer has bee…
-
CLINICAL_TRIALS research · 2009-08-18Clinical Trial Update: Attenuated SOX as First-line Treatment in Elderly Patients With Relapsed or Metastatic Gastric Cancer [Phase 2]
A Phase 2 trial is evaluating an attenuated SOX regimen (S-1 plus oxaliplatin) as first-line treatment for elderly patients with relapsed or…
-
CLINICAL_TRIALS trial_result · 2009-08-13Clinical Trial Update: Study Evaluating Isovorin in Advanced/Recurrent Gastric Cancer [Phase 3]
A Phase 3 trial evaluating Isovorin (leucovorin) in advanced or recurrent gastric cancer has completed; sponsor Wyeth, now part of Pfizer, c…
-
CLINICAL_TRIALS trial_result · 2009-07-10Clinical Trial Update: Quality of Life Among Long-Term Survivors of Resected Gastric Cancer
This update reports quality-of-life outcomes among long-term survivors after surgical resection of gastric cancer from a completed clinical …
-
CLINICAL_TRIALS research · 2009-07-09Clinical Trial Update: Ultra Structure Of Peritoneum At Electronic Microscopy In Control Subjects And Patients With Gastric Cancer
This completed clinical trial compares peritoneal ultrastructure by electron microscopy in control subjects and patients with gastric cancer…
-
CLINICAL_TRIALS trial_result · 2009-07-07Clinical Trial Update: Sorafenib as a Second Line Treatment in Patients With Advanced or Metastatic Gastric Cancer [Phase 2]
Phase 2 trial of sorafenib as second-line therapy for advanced or metastatic gastric cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2009-05-18Clinical Trial Update: Efficacy Study of TKcell in Advanced Gastric Cancer [Phase 1, Phase 2]
Notes an efficacy study of TKcell for advanced gastric cancer across Phase 1 and Phase 2; no results or current status are disclosed.